Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:19 PM
Ignite Modification Date:
2025-12-24 @ 10:19 PM
NCT ID:
NCT06376435
Eligibility Criteria:
Inclusion Criteria:
* Understand the research procedure and voluntarily sign the informed consent to participate in the study
* Subjects ≥18 years of age receiving synchronous/sequential chemotherapeutic therapy
* Patients with platelet count ≤100×109/L or platelet count decrease ≥ 50×109/L or platelet count \> 100×109/L but need to be prophylaxis with hexapopethanolamine tablets
* Researchers believe that subjects need to be treated with hexapopal.
Exclusion Criteria:
* The subjects are conducting clinical intervention studies
* Patients with known or expected allergy or intolerance to the active ingredient or excipient of hexapopar
* Pregnant or lactating women
* Other conditions deemed unsuitable for inclusion in the study by the researcher.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06376435
Study Brief:
Protocol Section:
NCT06376435